Advertisements


Allogene Therapeutics Files for IPO

Clinical-stage immuno-oncology company Allogene Therapeutics has filed with the SEC in regards to its initial public offering......»»

Category: blogSource: 247wallstSep 14th, 2018

Nabriva files new drug application with FDA for urinary tract infection drug

Nabriva Therapeutics submitted a new drug application Thursday with the Food and Drug Administration for Contepo, its experimental therapy developed to treat complicated urinary tract infections. Contepo is a potentially first-in-class intravenous.....»»

Category: topSource: bizjournalsNov 1st, 2018

Hoth Therapeutics Files For $10.5 Million IPO

Hoth Therapeutics Files For $10.5 Million IPO.....»»

Category: topSource: seekingalphaOct 19th, 2018

Allogene Therapeutics Inc (ALLO) President and CEO David D Chang Bought $720,000 of Shares

Related Stocks: ALLO,.....»»

Category: worldSource: nytOct 17th, 2018

Aclaris Therapeutics files to sell common stock, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2018

Intellia Therapeutics files mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 12th, 2018

Brainstorm Health: Allogene IPO, Medtronic Hack Concern, Pharmacy Gag Clause

Brainstorm Health Daily: October 11, 2018 Good afternoon, readers--This is Sy. Biotech’s red-hot IPO streak shows no signs of slowing down. In fact, on Thursday, cancer drug maker Allogene Therapeutics pulled .....»»

Category: europeSource: fortuneOct 11th, 2018

Allogene Therapeutics opens at $22, IPO priced at $18 per share

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Allogene Therapeutics indicated to open at $20.50, IPO priced at $18.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Allogene Therapeutics indicated to open at $23.50, IPO priced at $18.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Allogene Therapeutics 18M share IPO priced at $18.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2018

Allogene Therapeutics 18M share IPO priced at $18.00

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2018

Akari Therapeutics files to sell 445M ordinary shares for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Audentes Therapeutics files to sell $150M of common stock

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Nightstar Therapeutics files to sell 4M American Depositary Shares

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2018

Nightstar Therapeutics files to sell 4M American Depositary Shares

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 25th, 2018

Cytori Therapeutics files to sell 3.73M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 21st, 2018

Fate Therapeutics files to sell common stock, no amount given

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 20th, 2018

Crispr Therapeutics files to sell $200M in common stock

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 19th, 2018

Crispr Therapeutics files automatic mixed securities shelf

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 19th, 2018

Cesca Therapeutics files to sell 3.965M shares of common stock for holders

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 19th, 2018